See the DrugPatentWatch profile for doptelet
What is Doptelet (avatrombopag) and what does “Europa” mean for pricing?
“Doptelet” is the brand name for avatrombopag. “Europa” usually means the country pricing in Europe (for example, Germany, France, Italy, Spain, or the UK). Prices vary by country, pharmacy mark-ups, insurance/reimbursement status, and whether you’re paying retail or getting it through a public/insurer reimbursement scheme.
If you tell me the European country (and whether you mean list price at the pharmacy or reimbursed cost), I can narrow the answer to the right pricing context.
How is Doptelet typically priced in Europe?
Pricing in Europe is usually not a single “Europe-wide” number. You’ll commonly see differences between:
- Public reimbursement price vs. out-of-pocket retail price.
- Hospital vs. community pharmacy pricing arrangements.
- Tender/contract pricing for hospitals in some countries.
To give you an exact number, I’d need the specific country and whether you want pharmacy price or reimbursed price.
Why can the cost change between patients and prescriptions?
Even within the same country, your total cost can change because Doptelet dosing depends on your condition and lab monitoring (including platelet counts), so the number of tablets used per cycle can differ. That affects how much is billed per treatment period.
Can I find the cheapest way to get it?
Prices are often influenced by reimbursement rules and patient access programs. In some European countries, the drug is reimbursed only for specific indications and after certain criteria are met, which can substantially reduce patient out-of-pocket costs versus paying privately.
Quick questions to pin down the exact price
Reply with:
1) Which country in Europe? (e.g., Germany, France, Italy, Spain, Netherlands, UK)
2) Are you looking for the pharmacy list price or the reimbursed/patient out-of-pocket price?
3) Which indication is it for (if you know): ITP or another use case?
Sources: None provided in the prompt.